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ABSTRACT Fluorometric titration curves of erythrocyte membranes with increas-
ing lucensomycin have a sigmoid shape. This behavior, which was not present
when colloidal cholesterol suspensions were used, is, however, not peculiar to the
membrane structure, being also present in cholesterol-containing phospholipid
micelles. Addition of acetic acid induced or increased sigmoidicity. This behavior
can either be due to a true cooperativity in binding or to different fluorescence
yields of the various lucensomycin-membrane complexes. The latter hypothesis
appears to be slightly favored.
INTRODUCTION
In the accompanying paper (1) we have described the variations of fluorescence
emission and of absorbancy of lucensomycin upon interaction with cholesterol
molecules. With colloidal cholesterol suspensions, although cholesterol determina-
tions indicated the formation of LC2 complexes (L being the polyene and C the
binding site), both fluorescence and spectrophotometric titrations gave curves
compatible with a simple L + C = LC mechanism or with the equivalence of the
two binding sites. We report here evidence indicating that, in cholesterol-containing
lipid micelles or in erythrocyte membranes, the reaction is more complex, either
because of cooperativity, in the micelle or in the membrane, between the binding
sites for the polyene or because of a cooperative effect restricted to the ability to
fluoresce.
MATERIALS AND METHODS
As previously described (1).
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RESULTS
Fluorometric Measurements of the Binding to Erythrocyte Membranes
Fig. 1 illustrates how fluorescence intensity depended, at various lucensomycin
concentrations, upon the amount of membrane added. Using polyene concentra-
tions > 0.6 ,M, the fluorescence reached a maximal value corresponding to a
quantum yield of about 0.25. At lower lucensomycin concentrations, however, the
maximal fluorescence was significantly less, as if not all polyene molecules had
become fluorescent. Fig. 2 indicates how the maximal fluorescence reached de-
pended upon lucensomycin concentration. In some cases (i.e., at the lowest con-
centrations) it would even be shown that fluorescence, after having reached a maxi-
mum, decreased upon further addition of membranes (see insert of Fig. 1); this
decrease could not be attributed solely to an enhanced light-scattering effect of
membranes.
Titration curves of known amounts of membranes with varying lucensomycin
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FIGURE 1 Fluorometric titration of lucensomycin with erythrocyte membranes. Five
different concentrations of the polyene were used: 0.24pM (U); 0.36 1sM (0); 0.5 IAM (0);
0.8 AM (0l); 2.3 AM (A). Fluorescence (,v) is expressed as arbitrary units of emission at
410 nm upon excitation at 308 nm (see Methods). All values are normalized for lucenso-
mycin concentration. Membranes are expressed either as milligrams of protein (lower
scale) or micromoles of cholesterol (upper scale). In the insert, the full titration curve,
extending to high Mtot/Ltot ratios, of 0.24 AM lucensomycin (U) is reported.
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FIoURE 2 Relation between lucensomycin concentration and maidmal fluorescence which
may be attained upon addition of erythrocyte membranes.
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FIGURE 3 Fluorometnc titration of erythrocyte membranes with lucensomycin. Five
different concentrations of membranes were used, which, expressed as cholesterol, were:
0.95 «M (0); 3.15 "M (0); 8 IAM (A); 31.5 IAM (0). The dotted line indicates the ideal
behavior of the titration curve at very high membrane concentrations. All values are nor-
malized for membrane concentration.
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FioURE 4 Fluorometric titration of erythrocyte ghosts with lucensomycin in the absence
>x--) or presence (0-0O) of 3.7 AM N-acetyl-lucensomycin. The membrane con-
centration, expressed as cholesterol, was 3.6 &M.
4Ltot upM
BIoPHYsIcAL JOURNAL VOLUME 13 1973
0.8
FIGuRE 5 Fluorometric titration of erythrocyte ghosts in the absence (O---O) or pres-
ence (a- ) of 0.06% sodium dodecylsulfate; membrane concentration (as cholesterol):
3.6 AM.
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had, as shown in Fig. 3, a sigmoidal shape, which, though more apparent when
low amounts of membranes were used, was present in all cases. The slopes of the
initial region of the curves had, in a double logarithmic plot, values between 2.8
and 3.1. The maximal fluorescence reached, at "infinite" lucensomycin concentra-
tions, was strictly proportional to the membrane concentration; only if the polyene
was > 4 AM could a concentration quenching be detected.
If the increasing amounts of lucensomycin were added to a given membrane con-
centration in the presence of N-acetyl-lucensomycin, which, as mentioned in the
accompanying paper (1), did not fluoresce at neutral pH, the sigmoid character
of the titration curve decreased, reaching finally a hyperbolic shape (Fig. 4).
Addition of nonionic or anionic detergents (Triton X 100 [Rohm and Haas Co.,
Philadelphia, Pa.], Nonidet P40, sodium dodecylsulfate) caused the fluorescence
of the polyene-membrane complex to be quenched. As shown in Fig. 5, the whole
titration curve became flatter, but the sigmoid character remained unaffected.
Fluorescence upon Binding to Phospholipid-Cholesterol Micelles
As previously mentioned (1), addition of micelles prepared with the total lipid frac-
tion from beef erythrocytes to lucensomycin in aqueous solution gave results
superimposable, on a cholesterol basis, on those obtained with whole erythrocyte
ghosts. In this case too, the titration of known amounts of lipids with varying
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FIGURE 6 Fluorometric titration of 10:1 (w/w) lecithin-cholesterol micelles; cholesterol
concentration equals 3.25 MM (0 O) or 6.5 ,M (A -).
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lucensomycin had a sigmoidal shape. Curves with pronounced sigmoidicity were
also found upon titration with lucensomycin of micelles formed by egg lecithin and
cholesterol (Fig. 6).
Effect of Acetic Acid on Titration Curves of Colloidal Cholesterol and of
Erythrocyte Membranes
In the former paper of this series (1), we showed that titration curves of colloidal
cholesterol with increasing polyene did not show any sigmoidicity. A "cooperative"
pattern was instead present if cholesterol was included in a phospholipid micelle,
formed either by crude egg lecithin or by whole erythrocyte lipids. Preliminary ex-
periments with purified phospholipids have not so far led to definite conclusions
about the nature of the groups responsible for this effect. It was, however, found
that a pronounced sigmoidicity could be induced in titration curves of colloidal
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FIGURE 7 Above: Fluorometric titration of beef erythrocyte membranes (cholesterol
concentration: 7 juM) with lucensomycin, in the absence (- ~*) or presence of 0.43
M (o----or-) or 1.30 M (A---A--A) acetic acid. Below: Fluorometric titration of 5.2 ;uM
colloidal cholesterol with lucensomycin, in the absence (9 *) or presence of 2.17 M
(O--O) or 4.34 M (A-A-*-/\-,) acetic acid.
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cholesterol by addition of relatively small amounts of acetic acid (Fig. 7, below).
Even smaller amounts of acetic acid could increase the sigmoidicity of erythrocyte
membranes titration curves (Fig. 7, above). The maximal fluorescence obtainable
(at " infinite" lucensomycin) was not modified by such addition.
Estimate of Binding Characteristics by Nonfluorometric Means
The modifications of optical density which occur upon binding of lucensomycin to
cholesterol and to erythrocyte membranes can be utilized to obtain titration curves
based on measurements independent from fluorescence characteristics. In Fig. 8
is illustrated such a titration, corresponding approximately to the lowest one
(- * ) of Fig. 3. No sigmoidicity is apparent, though the shape of the curve
seems to indicate the presence of secondary phenomena.
Direct investigation of the binding of lucensomycin to erythrocyte membranes
could also be performed by equilibrium gel ifitration experiments, according to
Fairclough and Fruton (2). Unfortunately, only polyene concentrations above
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FiouRs 8 Spectrophotometirc titration of erythrocyte membranes (final cholesterol
concentration: 1.1 pM) with increasing amounts of lucensomycin. On the ordinates is re-
ported the difference of optical density at 319 nm, between the combined sample and the
sum of the absorbancies of membranes and polyene separately.
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FIGURE 9 Ordinates: area, expressed as nanomoles of lucensomycin, of the trough after the
membrane peak, when 150 A of erythrocyte membranes, corresponding to 213 nmol of
cholesterol, are passed through a 0.5 X 100 cm Sephadex G25 column equilibrated with
lucensomycin. Abscissas: lucensomycin concentration.
1.3 pM could be evaluated quantitatively, on the basis of their extinction coefficient
at 304 nm. A saturating value of approximately 0.38 pAmol lucensomycin per ,umol
of membrane cholesterol was obtained (Fig. 9), while an estimate of the dissociation
constant was beyond experimental reach.
Centrifugation of erythrocyte membranes-lucensomycin mixtures on 5-40%
sucrose gradients showed that the polyene, in the presence of excess membranes,
migrated in the fraction containing the membranes. The precision of this method
was, however, not sufficiently high to allow obtention of titration curves.
DISCUSSION
The data obtained in the present work indicate that, because of the sigmoid char-
acter of fluorescence vs. polyene titration curves, the stoichiometry of the binding
of lucensomycin (L) to erythrocyte membranes or to cholesterol-phospholipid
micelles (M) is not amenable to the simple L + M -= LMequilibrium.
By analogy with results obtained in protein systems (3, 4), such a behavior can
be accounted for by the existence in each micelle, or ghost, of several binding sites
for lucensomycin. Evidence presented in the accompanying paper (I) indicates
that polyenic antibiotics bind specifically to cholesterol. Some cholesterol molecules
may not, however, be available for binding, or each polyene moiety may require
more than a single cholesterol molecule, as shown by titration curves (Figs. 3 and
9) indicating a stoichiometric sterol-polyene ratio around 2.5. Nevertheless, in
each ghost or micelle the number of cholesterol molecules may be envisaged to be
high enough so as to allow for the existence of a multiplicity of binding sites.
The sigmoidal shape of the titration curves can be accounted for by two different
mechanisms. The first one would be that of a cooperative interaction between
binding sites, i.e., binding of the first lucensomycin molecule would favor binding
of subsequent ones. In a micelle, or in a ghost, each site M, able to bind a single
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polyene molecule, is surrounded by a number (q - 1) of similar sites with which
cooperative interaction occurs, this hypothesis shall be represented by the system:
L + MqK L MQ
L + LlMq L2Mq (1)
L + L(q.1) MQ LaMq
Fluorescence would, in this case, be proportional to the concentration of bound
lucensomycin, i.e.
q
(P JEi(L, Mq) (2)
E-1
so that
fP/(Mtot) = '(M1iganded)/(Mtot). (3)
po/(Mtot) expresses therefore the fractional saturation y of membrane sites, when
exposed to a given polyene concentration.
This model can also be, to a first approximation, treated by indicating the overall
reaction as:
K'
nL + M. (LM)nw1(4)
where K' is the association constant of this nth order reaction. Simple application
of mass law leads to the following equation (3, 4):
(Ltot)/(MOt)= y + [l/(Mtot)][V/K'(l - y)]lu&. (5)
At sufficiently high Mtot concentrations the second term on the right side vanishes
and y = 1, i.e. (p/(Mtot) reaches its maximum value 4I, for (Ltot)/(Mtot) = 1. In
fact, this would be true if we had expressed (Mtot) as the concentration of binding
sites; Fig. 3 shows that in erythrocyte ghosts, if (Mtot) is expressed as cholesterol
concentration, this ratio is around 0.42. This would indicate that in ghosts each
binding site is formed by approximately 2.5 cholesterol molecules. In colloidal
cholesterol micelles (see Fig. 3 of reference 1) a ratio of about 0.5 had been found.
As for the sigmoid character of the titration curves, at low Mtot concentrations
and at low fractional saturation (y) values, Eq. 5 becomes, if n > 1,
(Ltot)/(Mtot) , 1/(Mtot)Lv/K'(I - y)]1In = l/(Mtot)[(p/KNI(Mtot)]11n (6)
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and, in a double logarithmic plot,
log [sp/(Mtot)] = nlog (Ltot/Mtot) + an additive term. (7)
The initial parts of the curves of Fig. 3, plotted in a double logarithmic plot, yield
values of n around 3.
The first proposed mechanism would therefore be that of a real cooperativity
in the binding of lucensomycin to membranes. Since formation of a lipid micelle
is due to cooperative interaction between its constituents, such a model, which is
similar to that proposed by Changeux et al. (5) would be expected to hold whenever
the binding of a ligand to its target is favored by inclusion of this target into the
micelle. Cooperativity would not be present upon binding to a site not included in a
micelle, and would be decreased if some of the binding sites were already occupied
by nondetectable ligand analogues (e.g., N-acetyl-lucensomycin) or if the micelle
was altered by disrupting agents. The first two conclusions are supported by ex-
perimental results (see reference 1, and Fig. 4). As for the last one, addition of
detergents, though leading to decreased fluorescence, did not affect cooperativity
(Fig. 5); this treatment, however, does not completely disrupt the micelles but
rather alters their composition, so that this experiment cannot by itself be taken as
disproving this first proposed mechanism.
An alternative hypothesis would be that, though binding itself is not necessarily
cooperative, fluorescence is so: i.e. the equilibrium constants K1, K2, K8. . . Kq of
Eq. 1 have a distribution which may (but also may not) be statistical (i.e., Ki =
(q - i + 1/i) -K, where K is the intrinsic equilibrium constant), but only the LiM
complexes with several (i > 3) lucensomycin molecules have a relevant "weight"
in the production of fluorescence. This mechanism can, in first approximation, be
also expressed by Eq. 4, so that most of the experimental evidence is unable to
distinguish between the two hypotheses. Fluorescence is, however, in this case, an
index not of the fractional saturation y, but only of some LiM complexes.
The latter hypothesis is favored by the following facts:
(a) The maximal fluorescence reached upon addition, to given concentrations of
lucensomycin, of increasing amounts of erythrocyte membranes (Figs. 1 and 2)
is not strictly proportional to the concentration of the polyene. Moreover, fluo-
rescence declines upon further addition of membranes. Such a behavior would be
expected if fluorescence is related to the existence of LiMq species with i > 1 (or,
even better, if only the L2Mq species is fluorescent). In Fig. 10 is shown a theo-
retical titration curve in the simplest case where q = 2, assuming that the intrinsic
equilibrium constant is K = 4 AM1 (and therefore K1 = 8 uM-1 and K2 = 2 AM-1)
and that s = 'I'- (L2Mq): the results are qualitatively similar to those illustrated in
Fig. 1; a 20-40-fold decrease in the value of K1 (i.e. around 0.3 ,uM, with deviation
from statistical distribution), but not of K2, would give a better fit with the experi-
mental data obtained with erythrocyte ghosts.
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FIGURE 10 Theoretical titration curve of lucensomycin with cholesterol, assuming that
each site M of the cholesterol-containing micelles can bind two lucensomycin molecules.
The intrinsic equilibrium constant K was assumed 4 IAM-1, 1 and K2 after a statistical
distribution (ki = 8 pM-; K2 = 2 M-1) Lucensomycin concentrations: 5 ,M (A); 2 pM
(B); 0.5 ,uM (C); 0.2 ,M (D). On the ordinate is reported the percentage of L2M formed.
In the insert, curves (C) and (D) are reported with different scales.
(b) Addition of acetic acid induces sigmoidicity in titration curves of colloidal
cholesterol, and increases that of erythrocyte membranes. This would be explained,
though it is not the only possible explanation, by a quenching effect of acetic acid
on the LiMq species with lower values of i.
(c) Spectrophotometric evaluation of membrane-bound lucensomycin as a
function of varying polyene failed (Fig. 8) to show a sigmoid shape. Assuming
that absorbancy variations reflect the real binding of lucensomycin to cholesterol,
cooperativity would appear to be related only to the ability of some molecular
species to fluoresce, and not to reflect the characteristics of the binding itself. The
validity of spectrophotometric and circular dichroism data as indices of binding
is, however, far from being proven.
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A further support to this hypothesis arises from the finding by Engelman and
Rothman (6) that, in lecithin-cholesterol micelles, each cholesterol moiety is sur-
rounded by phospholipids and is therefore well separated from other cholesterol
molecules. More accurate evaluation of true binding parameters is, however, needed
to choose between the two proposed mechanisms.
As for the possible topography of the polyene molecules in the membranes, in
view of their effect on permeability a stacking of these large lactone rings on top
of each other, leading to formation of an aqueous channel, can be envisaged: such
a pattern has been shown to occur in crystals of polyenes (7). Fluorescence is,
however, apparently not due to the formation of an excimer, i.e. of an excited state
propagated to several polyene molecules, because in such a case the emission spec-
trum would be shifted to longer wavelengths (8). Lucensomycin can be visualized
as becoming fluorescent only when, in a hydrophobic milieu, it is sandwiched be-
tween two similar molecules, so that its amino- and carboxyl groups are neutralized
by interaction with adjacent polyenes.
From a functional point of view, lucensomycin, like other polyenic antibiotics,
causes a severe increase of membrane permeability, leading to alterations of cell
metabolism (9, 10). In the polyene range commonly used, this effect is strictly
proportional to the lucensomycin:cell ratio (10), with no indication of cooperative
effects. Other polyenes (e.g. amphotericin B, nystatin) have in fact been shown,
with artificial bilayers, to exhibit a 4th-12th order cooperativity leading to increased
conductance (11). The mechanism of formation of the aqueous pores, to which the
increased conductance is due, is still unknown, being not amenable to a simple ex-
traction of cholesterol from the membrane. Conspicuous rearrangements of the
membrane architecture around the binding site of the polyene are likely to take
place; cooperativity in the formation of pores would not, therefore, be necessarily
related to the stoichiometry of binding.
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